A chemiluminescent test for anti treponemal total antibodies, Liaison Treponema Screen test (LTS), was compared with Treponema Pallidum Particle Agglutination assay (TPPA) against 1022 regular blood donors and 2627 in-and-outpatients attending the laboratories of five hospitals. All positive and doubtful tests were confirmed by Western Blot (WB) and we have discussed the criteria of WB positivity. The results for blood donors were: nonreactive 1022 TPPA and 1021 LTS and doubtful 1 LTS (WB negative) with a concordance of 99.9%.The mean and median index values of the LTS tests (0.175 and 0.15 respectively) were much lower than the doubtful and positive cut-off index values (0.9 and 1.1 respectively).The results for the 2627 patients were: 2423 (92.2%) LTS and TPPA non reactive; 191 (7.3%) LTS and TPPA reactive; 13 (0.5%) LTS and TPPA discordant. Of the 13 patients with discordant tests (1 TPPA reactive vs. LTS nonreactive and 12 LTS reactive or doubtful vs. TPPA nonreactive) 1 was true positive (LTS reactive and TPPA nonreactive), 10 true negative (LTS reactive/doubtful and TPPA nonreactive) and 2 not verifiable. The sensitivity and specificity of LTS were 99.5% and 99.6% respectively; the sensitivity and specificity of TPPA were 99.0% and 100% respectively. In conclusion, LTS and TPPA are similar in sensitivity and specificity, but an automated analyzer as Liaison is more useful than TPPA in laboratories with high workload in syphilis screening.
INTRODUCTION
Syphilis is a disease in which diagnostic suspicion is more frequently related to anamnestic/epidemiological data than to the clinical picture itself (9, 15) ; except for the primary infection, the diagnosis is based on the finding of serological positivity but it is often impossible to understand whether the positive serological findings are relate to a past infection, or latent or ongoing disease. The serological diagnostic criteria, which have been redefined on the basis of the more widespread use of new treponemal tests and IgM antibodies, were changed mainly for confirmation criteria of screening tests. Now the screening is recommended with treponemal EIA (that detects both IgG and IgM), or TPPA or VDRL/RPR and TPHA and the positives must be confirmed with a different treponemal test. An immunoblot is recommended when the standard confirmatory test does not confirm the positive result (4-7, 10, 16) . The serological tests can be classified in two categories: treponemal tests for specific antibodies against treponema antigens, and aspecific non-treponemal tests for antilipoid antibodies that appear during the initial phase of syphilis but also in other situations, such as autoimmune diseases. In countries with advanced public healthcare services, syphilis is the sexually transmitted disease that has aroused the least media interest, and this has favoured its recrudescence; currently, screening is restricted to blood and tissue donations, pregnant women, AIDS patients, and patients with known risk behaviours. When screening blood donors, we cannot have any false negative results, therefore the greatest sensitivity is required; on the other hand, it is also important not to unnecessarily block blood bags or suspend donors on the basis of doubtful or false positive results, thus sensitivity needs to be combined with a high degree of specificity. The same consideration is valid for pregnant women, in whom non-treponemal tests may give rise to false positive findings. The optimal evaluation of a new test requires the use of a sufficiently large population of truly negative and positive patients, in whom the phase of the disease is known. In the absence of such a population with a confirmed diagnosis, the alternative is to compare the new test with the currently available reference tests. The aim of this study is to assess the diagnostic reliability of chemiluminescent Liaison Treponema Screen test (LTS) vs. the Treponema Pallidum Particle Agglutination assay (TPPA), which is considered to be the most reliable of the currently used routine tests. In the case of doubtful or positive findings, confirmation was by western blotting (WB) as a means of identifying the type of significant antibodies present in that sample. 
MATERIALS AND METHODS
Patient tests: Table 2 shows the LTS and TPPA results obtained in the 2627 samples from different patients tested by the laboratories of the five participating hospitals; 2423 were LTS and TPPA non reactive, 191 were LTS and TPPA reactive, 13 were discordant. the patient was LTS and TPPA highly reactive (a true positive), therefore the RPR was an early sign of positivity. The positive samples were confirmed by WB. Table 5 , plus the LTS-and TPPA-negative patient with a RPR value of 1/8 who subsequently proved to be a true positive), 2432 true negative (2422 LTS-and TPPA-negative cases -after removing the patient who subsequently proved to be positive -plus the ten patients with discordant LTS and TPPA results without any specific bands at WB), and two not verifiable (Table 5) , samples A/2 and A/6).
DISCUSSION
To asses the diagnostic reliability of LTS, we compared its results with those obtained using the TPPA, which is considered the most reliable routine test and that is used by the WHO to select positive and negative samples for the "SDI evaluation of Rapid Syphilis Diagnostics" (www.who.int/std_diagnostics/publications/manuals/ syphilis_evaluation.pdf; 2007). The LTS and TPPA detect IgM antibodies too, thus allowing the early identification of positive cases and making both tests more reliable for screening purposes (5- (Table 3 ) and, when associated with TPPA values of <1/320, low LTS values of Յ3.00 are likely to reflect the immunological memory of a past infection that is no longer active. In the reactive tests we used WB to detect the presence of specific antibody bands which, in the case of discordant test results, can confirm or not that the test reactivity is related to a significant antibody band. Other authors used WB to confirm positivity (1, 3, 11, 14) and their data indicate that the presence of at least three bands is required to confirm a diagnosis of syphilis (1, 3, 14) , but our findings show that sample of positive patients, confirmed by both LTS and TPPA, may have just a single band in WB. We have 22 of 191 LTS and TPPA-positive cases with a single WB band, and it is worth noting that only 9 of these have their LTS and TPPA values that were respectively less than <3 and <1/320. We think that a rigid band count could reduce the diagnosis of true positive cases (considering true positive also tests with specific antibody bands due to a past non active infection) and that the use of IgG WB in a less strict way, for the rare discordant cases, is useful to understand the presence of possible past infection. Positive findings with low LTS and/or TPPA values should in any case be reviewed critically and, if the clinical and epidemiological data are doubtful, must be integrated with a search for IgM or RPR and/or checked again after a short time in order to avoid missing early signs of positivity. In our samples there was only one case with an RPR value of 1/8 that was negative by LTS, TPPA and WB IgG with a weakly positive 47 kD IgM band, and which subsequently proved to be a true positive. Of the 204 reactive cases, 13 (6.4%) led to discordant LTS and TPPA results (Table 5) ; LTS has one more positivity than TPPA but also ten false positive results. The sensitivity of LTS was 99.5% (192 positive cases out of 193 true positive) and its specificity 99.6% (2422 negative cases out of 2432 true negatives); the sensitivity of TPPA was 99.0% (191 positive cases out of 193 true positives) and its specificity 100% (2432 negative cases out of 2432 true negatives); these excellent data are similar to the results of other two studies on LTS (8, 11) . In conclusion LTS and TPPA are similar in sensitivity and specificity, but LTS moreover may be fully automated and the data can be transferred directly to a laboratory's information system, which is very useful when it is necessary to screen large numbers of samples (such as in a blood bank) and in cases specifically requiring secure and traceable data transfer, such as investigations for organ transplants. Both LTS and TPPA can be used as stand-alone screening tests or as confirmatory tests.
